Deferasirox Patent Expiration
Deferasirox is used for treating allergies and allergic reactions. It was first introduced by Novartis Pharmaceuticals Corp
Deferasirox Patents
Given below is the list of patents protecting Deferasirox, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Exjade | US6465504 | Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
Apr 05, 2019
(Expired) | Novartis |
| Exjade | US6596750 | Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
Jun 24, 2017
(Expired) | Novartis |
| Jadenu | US6465504 | Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
Apr 05, 2019
(Expired) | Novartis Pharms Corp |
| Jadenu | US6596750 | Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
Jun 24, 2017
(Expired) | Novartis Pharms Corp |
| Jadenu | US9283209 | Oral formulations of deferasirox | Nov 21, 2034 | Novartis Pharms Corp |
| Jadenu Sprinkle | US6465504 | Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
Apr 05, 2019
(Expired) | Novartis |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Deferasirox Generics
Several generic applications have been filed for Deferasirox. The first generic version for Deferasirox was by Actavis Elizabeth Llc and was approved on Jan 26, 2016. And the latest generic version is by Mylan Pharmaceuticals Inc and was approved on May 17, 2024.
Given below is the list of companies who have filed for Deferasirox generic.
1. STEVENS J
Jerome Stevens Pharmaceuticals Inc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Stevens J.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 90MG | tablet | Discontinued | ORAL | N/A | Dec 27, 2019 |
| 360MG | tablet | Discontinued | ORAL | N/A | Dec 27, 2019 |
| 180MG | tablet | Discontinued | ORAL | N/A | Jun 15, 2020 |
2. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG | tablet, for suspension | Prescription | ORAL | AB | Jan 26, 2016 |
| 125MG | tablet, for suspension | Prescription | ORAL | AB | Jan 26, 2016 |
| 500MG | tablet, for suspension | Prescription | ORAL | AB | Jan 26, 2016 |
| 360MG | tablet | Prescription | ORAL | AB | Dec 13, 2019 |
| 90MG | tablet | Prescription | ORAL | AB | Dec 13, 2019 |
| 180MG | tablet | Prescription | ORAL | AB | Dec 13, 2019 |
3. MYLAN
Mylan Pharmaceuticals Inc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 180MG | granule | Prescription | ORAL | AB | May 3, 2024 |
| 360MG | granule | Prescription | ORAL | AB | May 3, 2024 |
| 90MG | granule | Prescription | ORAL | AB | May 3, 2024 |
| 250MG | tablet, for suspension | Prescription | ORAL | AB | May 17, 2024 |
| 125MG | tablet, for suspension | Prescription | ORAL | AB | May 17, 2024 |
| 500MG | tablet, for suspension | Prescription | ORAL | AB | May 17, 2024 |
4. CIPLA
Cipla Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 90MG | granule | Prescription | ORAL | AB | Feb 23, 2022 |
| 360MG | granule | Prescription | ORAL | AB | Feb 23, 2022 |
| 180MG | granule | Prescription | ORAL | AB | Feb 23, 2022 |
5. BIONPHARMA
Bionpharma Inc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 250MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 125MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
6. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 360MG | granule | Prescription | ORAL | AB | Nov 19, 2021 |
| 90MG | granule | Prescription | ORAL | AB | Nov 19, 2021 |
| 180MG | granule | Prescription | ORAL | AB | Nov 19, 2021 |
| 250MG | tablet, for suspension | Discontinued | ORAL | N/A | Sep 23, 2022 |
| 500MG | tablet, for suspension | Discontinued | ORAL | N/A | Sep 23, 2022 |
| 125MG | tablet, for suspension | Discontinued | ORAL | N/A | Sep 23, 2022 |
7. AMNEAL
Amneal Eu Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 180MG | granule | Discontinued | ORAL | N/A | Feb 9, 2021 |
| 360MG | granule | Discontinued | ORAL | N/A | Feb 9, 2021 |
| 90MG | granule | Discontinued | ORAL | N/A | Aug 2, 2021 |
8. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 360MG | tablet | Prescription | ORAL | AB | May 27, 2021 |
| 180MG | tablet | Prescription | ORAL | AB | May 27, 2021 |
| 90MG | tablet | Prescription | ORAL | AB | May 27, 2021 |
9. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 180MG | tablet | Prescription | ORAL | AB | Oct 16, 2023 |
| 90MG | tablet | Prescription | ORAL | AB | Oct 16, 2023 |
| 360MG | tablet | Prescription | ORAL | AB | Oct 16, 2023 |
10. ANNORA PHARMA
Annora Pharma Private Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Annora Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 360MG | granule | Prescription | ORAL | AB | Sep 22, 2022 |
| 90MG | granule | Prescription | ORAL | AB | Mar 16, 2023 |
| 180MG | granule | Prescription | ORAL | AB | Sep 22, 2022 |
11. PIRAMAL HLTHCARE UK
Piramal Healthcare Uk Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Piramal Hlthcare Uk.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 90MG | tablet | Prescription | ORAL | AB | Dec 30, 2019 |
| 360MG | tablet | Prescription | ORAL | AB | Dec 30, 2019 |
| 180MG | tablet | Prescription | ORAL | AB | Jun 15, 2020 |
12. AUCTA
Aucta Pharmaceuticals Inc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Aucta.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 90MG | granule | Prescription | ORAL | AB | Mar 9, 2021 |
| 360MG | granule | Prescription | ORAL | AB | Mar 9, 2021 |
| 180MG | granule | Prescription | ORAL | AB | Mar 9, 2021 |
13. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 125MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 250MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 500MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 90MG | tablet | Prescription | ORAL | AB | Jan 2, 2020 |
| 360MG | tablet | Prescription | ORAL | AB | Jan 2, 2020 |
| 180MG | tablet | Prescription | ORAL | AB | Jun 15, 2020 |
14. MSN
Msn Laboratories Private Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Msn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 90MG | granule | Prescription | ORAL | AB | Apr 20, 2022 |
| 500MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 125MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 250MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 360MG | granule | Prescription | ORAL | AB | Mar 17, 2021 |
| 180MG | granule | Prescription | ORAL | AB | Mar 17, 2021 |
15. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 250MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 125MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 360MG | granule | Prescription | ORAL | AB | Jul 14, 2020 |
| 90MG | granule | Prescription | ORAL | AB | Jul 14, 2020 |
| 180MG | granule | Prescription | ORAL | AB | Jul 14, 2020 |
16. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 360MG | tablet | Prescription | ORAL | AB | Nov 20, 2019 |
| 90MG | tablet | Prescription | ORAL | AB | Nov 20, 2019 |
| 500MG | tablet, for suspension | Discontinued | ORAL | N/A | May 5, 2020 |
| 125MG | tablet, for suspension | Discontinued | ORAL | N/A | May 5, 2020 |
| 250MG | tablet, for suspension | Discontinued | ORAL | N/A | May 5, 2020 |
| 180MG | tablet | Prescription | ORAL | AB | Jun 15, 2020 |
17. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, for suspension | Prescription | ORAL | AB | Jan 6, 2020 |
| 250MG | tablet, for suspension | Prescription | ORAL | AB | Jan 6, 2020 |
| 125MG | tablet, for suspension | Prescription | ORAL | AB | Jan 6, 2020 |
18. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 250MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 125MG | tablet, for suspension | Prescription | ORAL | AB | Nov 20, 2019 |
| 360MG | tablet | Prescription | ORAL | AB | Nov 20, 2019 |
| 90MG | tablet | Prescription | ORAL | AB | Nov 20, 2019 |
| 180MG | tablet | Prescription | ORAL | AB | Jun 15, 2020 |